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Abstract
Background: Determinants of the clinical presentation of the leishmaniases are poorly understood but
Leishmania species and strain differences are important. To examine the relationship between clinical
presentation, species and isoenzyme polymorphisms, 56 Leishmania isolates from distinct presentations of
American tegumentary leishmaniasis (ATL) from Ecuador were analyzed.
Methods: Isolates were characterized by multilocus enzyme electrophoresis for polymorphisms of 11
isoenzymes. Patients were infected in four different ecologic regions: highland and lowland jungle of the Pacific
coast, Amazonian lowlands and Andean highlands.
Results: Six Leishmania species constituting 21 zymodemes were identified: L. (Viannia) panamensis (21 isolates,
7 zymodemes), L. (V.) guyanensis (7 isolates, 4 zymodemes), L. (V.) braziliensis (5 isolates, 3 zymodemes), L.
(Leishmania) mexicana (11 isolates, 4 zymodemes), L. (L.) amazonensis (10 isolates, 2 zymodemes) and L. (L.) major
(2 isolates, 1 zymodeme). L. panamensis was the species most frequently identified in the Pacific region and was
associated with several clinical variants of cutaneous disease (CL); eight cases of leishmaniasis recidiva cutis (LRC)
found in the Pacific highlands were associated with 3 zymodemes of this species. Mucocutaneous leishmaniasis
found only in the Amazonian focus was associated with 3 zymodemes of L. braziliensis. The papular variant of CL,
Uta, found in the Andean highlands was related predominantly with a single zymodeme of L. mexicana.
Conclusion: Our data show a high degree of phenotypic variation within species, and some evidence for
associations between specific variants of ATL (i.e. Uta and LRC) and specific Leishmania zymodemes. This study
further defines the geographic distribution of Leishmania species and clinical variants of ATL in Ecuador.
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Ecuador straddles the Andes and is crossed by the Equator
and is home to extremely diverse ecologic conditions.
American tegumentary leishmaniasis (ATL) in Ecuador
occurs throughout the tropical Amazon and Pacific
coastal regions and in some inter-Andean valleys. Accord-
ing to the Ecuadorian Ministry of Health, human cases
have been reported from 20 of the country's 22 provinces
and an estimated 3.1 to 4.5 million people are considered
to be at risk of infection with 3,000–4,500 new cases
occurring annually [1].
Differences in clinical presentations and severity of the
leishmaniases are explained by interactions between par-
ticular molecular and biologic characteristics of different
Leishmania species, host genetics and immunity and, envi-
ronmental factors [2,3]. Although it is generally accepted
that major clinical forms of ATL may be caused by specific
Leishmania species, the relationship between Leishmania
zymodemes and clinical presentation remains unclear [4].
To date, most studies investigating the relationship
between polymorphisms and clinical disease have pro-
vided little evidence for strong associations [5-9], proba-
bly because of the substantial variability among the
etiological agents of ATL at the subgenus level, with at
least 15 species described [10]. In addition, Leishmania
species in the New World are highly diverse genetically as
reported from Brazil, Colombia, French Guiana and Peru
[7-9,11,12].
ATL in Ecuador constitutes a group of diseases with a wide
spectrum of clinical variations [13,14] and atypical pres-
entations [15]. Six Leishmania species had been identified
as causative agents of ATL in this country: L. (Viannia) bra-
ziliensis, L. (V.) panamensis, L. (V.) guyanensis, L. (Leishma-
nia) mexicana, L. (L.) amazonensis and L. (L.) major-like
[13,16-19]. However, few parasite isolates have been ana-
lyzed for genetic diversity or phenotypic characterization
by isoenzyme polymorphisms and a survey of 28 human
stocks isolated from single and multiple CL ulcers showed
a high degree of genetic diversity within L. panamensis/L.
guyanensis species [20].
The characterization and identification of causative spe-
cies and zymodeme phenotypes, and their geographic dis-
tribution together with the clinical disease caused
provides important information for the design, prioritiza-
tion (e.g. according to risk of mucosal disease), and
implementation of control programs for this important
disfiguring parasitic infection. In the current study, we
report the diversity of Leishmania species and zymodeme
phenotypes isolated from clinical lesions from 56 patients
with varying clinical presentations of ATL from 4 different
geographic regions of Ecuador.
Methods
Origin, sampling, isolation and cultivation of Leishmania 
stocks
Twenty-nine parasite isolates included in this study were
sampled between 2000 and 2001 in the Leishmaniasis
Reference Center of the Central University, and the
remaining isolates were obtained during an active search
for patients infected in the Pacific highlands and low-
lands, Amazonian lowlands and, in the Andean region.
None of the patients had been living or infected outside
Ecuador.
Ecologically, (i) the highlands (500–1,000 m altitude)
and (ii) lowlands (<500 m) of the Pacific region are sub-
tropical and tropical humid rainforest, respectively. Both
zones are predominantly forest cleared for cattle ranching
or cultivation of banana, cocoa, coffee, and African palm
oil; the ambient temperature ranges 15–22°C in the high-
lands and 24–28°C in the lowlands. (iii) Amazonian low-
lands (100–500 m elevation) are located East of the Andes
and are covered by dense tropical rainforest with temper-
atures varying 25–29°C and high humidity. (iv) inter-
Andean valleys (Huigra and Paute) are at 1,200–2,500 m
elevation with temperatures ranging from 12–18°C and
scarce vegetation (Figure 1).
Leishmania isolates were obtained by aspiration of lesions
from patients with suspected CL or MCL and aspirates
were cultivated directly in USMARU biphasic medium as
described previously [21]. The parasites were bulk-cul-
tured in RPMI-1640 medium with 20% fetal calf serum.
They were harvested by centrifugation (10,000 g × 10
min) and washed thrice in phosphate-buffered saline (pH
7.2) as described [22]. Parasites pellets were stored at -
80°C until isoenzyme analysis. All patients provided writ-
ten consent to participate in the study and the protocol
was approved by the ethical committee of the Central
University of Quito, Ecuador.
Isoenzyme characterization
Sample preparation, electrophoresis and staining proce-
dures were followed as described [22,23]. Cellulose ace-
tate plates (Sebiagel, Moulineaux, France) were used and
assays were repeated twice. In this study, we have assayed
each Ecuadorian isolate and WHO reference strain for the
activity of the following 11 enzymatic systems: malate
dehydrogenase (EC 1.1.1.37, MDH); malic enzyme (EC
1.1.1.40, ME); 6-phosphogluconate dehydrogenase (EC
1.1.1.44, 6-PGD); glucose-6-phosphate dehydrogenase
(EC 1.1.1.49, G-6-PD); mannose phosphate isomerase
(EC 5.3.1.8, MPI); glucose phosphate isomerase (EC
5.3.1.9, GPI); alanine aminotransferase (EC 2.6.1.2,
ALAT); aspartate aminotransferase (EC 2.6.1.1, ASAT);
phosphoglucomutase (EC 2.7.5.1, PGM); pyruvate kinase
(EC 2.7.1.40, PK) and nucleoside hydrolase (inosine) (ECPage 2 of 9
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Map of Ecuador showing the geographic locations (regions and provinces) of Leishmania species identified in this studyFigure 1
Map of Ecuador showing the geographic locations (regions and provinces) of Leishmania species identified in 
this study. The shaded area shows the Andean plateau (>1,000 m altitude). Dotted areas show highland jungle or Andean 
slopes (400–1,000 m elevation). The tropical rainforest of Pacific coastal and Amazon regions are shown in white. Each letter 
represents one isolate.
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obtained from the cryobank of London School of Hygiene
and Tropical Medicine, were used in this study for species
identification: L. (V.) braziliensis (MHOM/BR/75/
M2903); L. (V.) panamensis (MHOM/PA/71/LS94); L. (V.)
guyanensis. (MHOM/BR/75/M4147); L. (V.) peruviana
(MHOM/PE/84/LC39); L. (V.) naiffi (MDAS/BR/79/
M5533); L. (L.) mexicana (MNYC/BZ/62/M379); L. (L.)
amazonensis (MHOM/BR/73/M2269); L. (L.) chagasi
(MHOM/BR/74/M2682) and, L. (L.) major (MHOM/SU/
73/5ASKH).
Data analysis
Each isolate was assessed according to the position of the
electrophoretic bands for all 11 enzymes. Each electro-
phoretic band was considered as a separate character and
was numbered from the most distal to the anodic point in
each zymogram. Zymodemes were identified according to
the pattern of electrophoretic profiles for the 11 enzymes
as previously described [24]. Identification of the Ecuado-
rian isolates was performed by comparing electrophoretic
profiles with WHO reference Leishmania strains. Hierar-
chical cluster analysis was used to summarize the relation-
ships between zymodemes using Jaccard's coefficient of
similarities [25]. Phenograms were constructed by analyz-
ing each electrophoretic band as a unit character, by con-
struction of a matrix with the presence or absence of
electrophoretic bands using the interactive molecular evo-
lutionary genetics analysis (MEGA) software, version 3.0
[26].
Results
A total of fifty-six Leishmania isolates were obtained from
fifty-six different subjects with ATL in Ecuador. Individu-
als were infected in four different bioclimatic geographic
areas in 12 provinces (Figure 1). Of the 56 subjects stud-
ied, 52 presented with cutaneous lesions with a wide vari-
ety of clinical presentations: 30 ulcers, 9 small papules or
Uta-like, 8 leishmaniasis recidiva cutis (LRC), 2 sporotri-
choid or pian-bois, 1 disseminated (DL), 1 erysipeloid
and 1 with diffuse cutaneous leishmaniasis (DCL). The
remaining four presented with mucocutaneous leishma-
niasis (MCL) or espundia.
In total, six Leishmania species were identified revealing 21
different zymodemes (Table 1). Of the 56 isolates, 21
(37.5%) were typed as L. panamensis revealing 7 different
zymodemes; 11 (19.6%) as L. mexicana with 4 zymo-
demes; 10 (17.8%) as L. amazonensis with 2 zymodemes;
7 (12.5%) as L. guyanensis with 4 zymodemes; 5 (8.9%) as
L. braziliensis with 3 zymodemes and 2 (3.6%) as L. major
with one zymodeme. The zymodeme composition is
shown in Table 2. None of the Leishmania zymodemes
present in Ecuador of L. braziliensis, L. mexicana and L.
major were identical to the Leishmania WHO reference
strains and, none of the Ecuadorian stocks were matched
to the WHO reference strains for L. (V.) peruviana, L. (V.)
naiffi or L. (L.) chagasi (Figure 2A and 2B).
There was some evidence for geographic restriction of
Leishmania species: L. panamensis, L. guyanensis and L.
amazonensis were isolated from 3 regions (not from the
inter-Andean); L. braziliensis was isolated only from the
Amazon lowlands; L. mexicana was identified almost
exclusively in the inter-Andean region, although one iso-
late of this species was identified in the Pacific lowlands
(Figure 1).
Findings for each of the 56 isolates are provided in Table
1 showing Leishmania species and zymodeme identified
for each of the 4 ecologic regions in Ecuador. In the Pacific
coastal highlands, 25 human isolates were studied, 12
were obtained from cutaneous ulcers and 13 from atypical
presentations (LRC, sporotrichoid, erysipeloid and DL);
three species, L. panamensis, L. guyanensis and L. amazonen-
sis and 10 different zymodemes were identified as causa-
tive organisms. Three zymodemes of L. panamensis (Z3, Z4
and Z5) were the only parasites associated with LRC (See
Figure 3 for clinical characteristics and Figure 2A for
zymodemes and their distance with WHO L. panamensis).
Interestingly, Z3 was identified also in other atypical vari-
ants of CL as disseminated and erysipeloid. Ulcers were
associated with 8 zymodemes from the 3 species circulat-
ing in Pacific highlands. In the Pacific lowlands, 10 iso-
lates were studied, of which 9 came from single or
multiple CL ulcers and 1 from a patient with DCL. Five
species with 7 different zymodemes were identified from
these isolates. The case of DCL was associated with Z17 of
L. mexicana.
Ten isolates were analyzed from the Amazon lowlands of
which four came from MCL (Figure 4) and 6 from CL
ulcers. Four species and 6 zymodemes were identified.
Three zymodemes of L. braziliensis (Z6, Z9 and Z10) were
associated with the isolates from MCL patients. Eleven
isolates were studied from the inter-Andean valley region,
7 isolates from Paute and 4 from Huigra, of which 10 were
identified as 3 zymodemes (Z18, Z19 and Z20) of L. mex-
icana and one a single zymodeme of L. major. Most clinical
lesions in this region were crusted papules (Uta-like)
lesions (Figure 5).
The phenograms (Figure 2) show that the Leishmania sub-
genera, Viannia and Leishmania, form distinct groups. The
genetic distance (Jaccard distances) between the two sub-
genera was over 0.9. Figure 2A shows the relationships
between different zymodemes isolated from the subtropi-
cal and tropical Pacific and Amazon geographic regions,
while Figure 2B shows the same for the inter-Andean
zymodemes. Different species were considered have Jac-Page 4 of 9
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demes, including WHO reference strains, within the
Viannia group (lower branch of phenogram) could be
divided into five main species clusters for L. panamensis, L.
guyanensis, L. naiffi, L. braziliensis, and L. peruviana. The
four species of Leishmania subgenus included in this study
(L. mexicana, L. amazonensis, L. major, and L. chagasi)
revealed 10 zymodemes (upper branch of phenogram),
10 Ecuadorian isolates were identified as L. amazonensis
and two isolates as L. major (Z21). From the eleven iso-
lates identified as L. mexicana involving 4 zymodemes,
Z20 was the only zymodeme identified in 5 out of 8 Uta
lesions and confined to Paute. No isolates of Viannia sub-
genus were found in the inter-Andean region.
Discussion
The data from this study shows a great diversity of Leish-
mania species and zymodeme phenotypes isolated from a
wide spectrum of clinical forms of ATL in Ecuador. The
diversity in the parasite populations may contribute to the
highly variable clinical spectrum of leishmaniasis
observed in this study and previous studies [13-16,27]. A
high degree of enzymatic polymorphisms in Leishmania
parasites has been reported previously in Ecuador [20],
and also in the neighboring countries of Colombia, Brazil
and Peru [8,9,12]. The findings of higher molecular diver-
sity in species isolated from subtropical and tropical
regions of the Pacific coast in this study rather than from
the inter-Andean region could be related to the greater
number of animal reservoirs and sandfly fauna encoun-
tered in these regions [28,29]. We report for the first time
in Ecuador enzymatic polymorphism of L. amazonensis, L.
mexicana and L. braziliensis, and have characterized Leish-
mania from mucocutaneous lesions.
The present study provides evidence that some of the dis-
tinct clinical forms of ATL are associated with specific
Leishmania species and some may be related with a
restricted number of zymodemes. Thus, MCL was associ-
ated only with L. braziliensis, LRC and other atypical pres-
entations of CL with L. panamensis and, Uta lesions with
L. mexicana. The evidence for associations of specific
zymodemes with clinical variants was observed only for
LRC and Uta; three zymodemes of L. panamensis associ-
ated with all 8 patients with LRC, and 1 zymodeme of L.
mexicana related with 5/8 cases of Uta. It has been sug-
gested that clades of L. braziliensis genotypes may be asso-
ciated by specific cutaneous, mucosal or disseminated
manifestations [9] but our data provides limited evidence
for this and is in agreement with other studies [5-8,11]. L.
braziliensis was the only species isolated from MCL lesions
and previous studies in Brazil, Colombia and Peru have
Table 1: Distribution of Leishmania species and zymodemes by lesion type and geographic origin
Geographical region
Leishmania species Zymodeme Pacific lowlands Pacific highlands inter-Andean valleys Amazonian lowlands
L. L. amazonensis Z1 ulcer (1) ulcer (1) - ulcer (1)
Z2 ulcer (4) ulcer (3) - -
L. V. panamensis Z3 - LRC (4), ulcer (1), E 
(1), DL (1)
- -
Z4 - LRC (2) - -
Z5 - LRC (2), ulcer (1) - -
Z7 ulcer (1) - - -
Z8 ulcer (1) ulcer (1) - ulcer (1)
Z15 - S (1) - -
Z16 - ulcer (2), papular (1), 
S (1)
- -
L. V. guyanensis Z11 ulcer (1) - - -
Z12 - - - ulcer (3)
Z13 - ulcer (2) - -
Z14 - ulcer (1) - -
L. V. braziliensis Z6 - - - ulcer (1), MCL (1)
Z9 - - - MCL (1)
Z10 - - - MCL (2)
L. L. mexicana Z17 DCL(1) - - -
Z18 - - ulcer (3), papular (1) -
Z19 - - papular (1) -
Z20 - - papular (5) -
L. L. major Z21 ulcer (1) - papular (1) -
Number of isolates are shown in parentheses. DCL, diffuse cutaneous leishmaniasis; LRC, leishmaniasis recidiva cutis; MCL, mucocutaneous 
leishmaniasis; S, sporotrichoid; E, erysipeloid.Page 5 of 9
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species [8,9,30].
L. panamensis believed to cause generally cutaneous ulcers
[31] in this study was associated with all lesions of LRC
and other presentations (i.e., erysipeloid, sporotrichoid,
and disseminated). However, the latter lesions were
observed only in the Pacific highlands (Andes slopes) and
it is possible that factors specific to this environment may
contribute to atypical presentations of ATL such as vol-
canic soil [32].
L. mexicana infection presented in children as small
papules (Uta) in the inter-Andean region, lesions that
heal spontaneously in a few months leaving an impercep-
tible scar. L. mexicana isolated in the Andes seems to have
a unique life cycle, in which only Lu. ayacuchensis and
domestic dogs are incriminated as vector and reservoir,
respectively [28,33]. Interestingly, in the Peruvian Andes,
a similar clinical presentation is caused by L. peruviana
[34]. It has been speculated that UV radiation, which is
stronger in the highlands, may also play a role in the out-
come of infection [35].
This study demonstrated geographic restriction of some
Leishmania species in Ecuador. Leishmania subgenus was
generally observed in the inter-Andean region, whereas
Viannia was observed generally in forested areas. How-
ever, there was some overlap with L. mexicana and L.
major, also being isolated from the Pacific region. L. pana-
mensis was the predominant species identified in the
Pacific highlands (76.0% of all isolates) and L. mexicana
predominated in the inter-Andean region (90.9% of iso-
lates). In general, the geographic distribution of Leishma-
nia species observed in this study is in agreement with
previous reports [16,18-20]. Nevertheless, we did not
identify any isolates of L. braziliensis from the Pacific
region, and this finding may explain the rarity of MCL in
this region. Although mucosal involvement caused by this
and others Viannia species has been reported in the
Colombian Pacific coastal [8], we and others clinical
investigators have never diagnosed espundia originating
in the Pacific coastal area of the country.
Interestingly, L. amazonensis was identified in 17% of the
56 isolates examined. This figure is higher than previously
reported but our data confirmed the wide distribution of
Table 2: Enzymatic profiles of the 21 zymodemes found in Leishmania isolates from Ecuador
Enzymes
Leishmania spp. and zymodeme G-6PD 6-PGD ME MDH ASAT ALAT GPI MPI PGM PK NH
L. L. amazonensis
Z1 2 1 1 2 5 2 3 2 4 2 2
Z2 2 1 1 2 4 2 3 2 4 2 2
L. V. panamensis
Z3 2 4 2 1,5 1 3 1,2 4 3 1 1,3
Z4 2 4 2 1,5 2 3 1,2 4 3 1 1,3
Z5 2 4 3 1,5 1 3 1,2 4 3 1 1,3
Z7 1 3 3 1,5 2 3 1,2 4 3 1 1,3
Z8 2 4 3 1,5 2 3 1,2 4 3 1 1,3
Z15 1 4 3 1,5 1 3 1,2 4 2 1 1,3
Z16 2 2 2 1,5 1 3 1,2 4 3 1 1,3
L. V. braziliensis
Z6 2 3 2 1,3 3 4 1,2 3 2 3 1,4
Z9 2 3 3 1,3 2 6 1,2 3 2 3 1,4
Z10 2 3 2 1,3 2 6 1,2 3 2 3 1,4
L. V. guyanensis
Z11 1 2 3 1,5 2 3 1,2 4 4 1 2,3
Z12 1 2 3 1,5 2 5 1,2 4 3 1 2,3
Z13 1 2 3 1,5 1 4 1,2 4 3 1 2,3
Z14 2 4 3 1,5 1 4 1,2 4 3 1 2,3
L. L. mexicana
Z17 3 1 1 1,3 4 1 4 1 1 3 2,4
Z18 3 2 3 2 5 1 4 3 2 3 4,6
Z19 3 2 3 2 5 1 4 3 1 3 4,6
Z20 4 2 2 3 5 1 4 3 2 3 4,6
L. L. major
Z21 4 2 4 1 2 2 2 1 4 3 4,6Page 6 of 9
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[13,16,17,19] and we identified this species in the Ama-
zon region. The original observation of L. major-like infec-
tion in Ecuador recorded by Hashiguchi et al., [18] has
been confirmed in the present study. Furthermore, we
have demonstrated that these parasites belong to different
zymodeme of the WHO reference strain (Turkmen,
USSR). L. major has been identified also in Brazil, Vene-
zuela, Paraguay and Mexico [9,24,36]. It has been
reported that L. naiffi is widespread in South American
countries [37] with one patient possibly infected in Ecua-
dor. In the current study we were unable to isolate any
parasite with phenotypic similarity to the WHO reference
stock for this species.
Lesions of Leishmaniasis recidiva cutis (LRC) on the forearm of a 6-years old boyFigure 3
Lesions of Leishmaniasis recidiva cutis (LRC) on the 
forearm of a 6-years old boy. Red-brown papules 
appeared around a healed scar and progressed intermittently 
over a period of 3 years, leaving an extensive depressed scar 
(center). All parasites isolated from LRC were identified as L. 
(V.) panamensis, entailing 3 (Z3-Z5) out of 7 zymodemes.Phenogram of the 56 Ecuadorian Leishmania isolates and 9 WHO eference strainsFigure 2
Phenogram of the 56 Ecuadorian Leishmania isolates 
and 9 WHO reference strains. 2A shows the 17 zymo-
demes from patients infected in the forest of Pacific and 
Amazon region. 2B shows 4 zymodemes identified from the 
inter-Andean area. The Leishmania species identified are 
shown at the end of the branches with the type of clinical 
lesions and number of subjects in parentheses. Lamaz – L. 
amazonensis, Lbraz – L. braziliensis, Lguy – L. guyanensis, Lmex 
– L. mexicana, Lpan – L. panamensis, Lperuv – L. peruviana. U, 
ulcer; DCL, diffuse cutaneous leishmaniasis; LRC, leishmania-
sis recidiva cutis; E, erysipeloid; S, sporotrichoid; P, papular 
or Uta-like, and MCL, mucocutaneous leishmaniasis.
 Z1.WHO.Lamaz.U(3)
 Z2.Lamaz.U(7)
 WHO.Lchagasi
 Z17.Lmex.DCL(1)
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Mucocutaneous leishmaniasis (MCL) or espundiaFigure 4
Mucocutaneous leishmaniasis (MCL) or espundia. 
Active lesions in nasal mucosal tissue with septal perforation 
and disfigurement of the nose and swelling of upper lip in a 
38-years old man native from the Amazonian lowlands. Para-
sites from MCL cases were identified as L. (V.) braziliensis but 
no relationship with a specific zymodeme was observed.Page 7 of 9
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We have identified six Leishmania species and 21 zymo-
demes associated with parasites isolated from 56 patients
with different clinical forms of leishmaniasis from diverse
ecological areas of Ecuador. Our data show a high degree
of species and enzymatic polymorphism and some evi-
dence for major clinical presentations of leishmaniasis to
be associated with specific Leishmania species but limited
evidence with zymodemes. Our data further defines the
geographic distribution of leishmaniasis in Ecuador with
respect to species distribution and the clinical presenta-
tions observed. The mapping of the geographic distribu-
tion of Leishmania species and clinical disease will be
important both regionally and nationally for designing
control programs or interventional field trials for drugs or
vaccines.
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